Phase I/IIa Study: RR001 Administered Following Chemotherapy Cycles for Patients With Locally Advanced Pancreatic Carcinoma
Clinical trial NCT06861452 · RECRUITING
Trial details
- NCT number
- NCT06861452
- Sponsor
- EIR Biotherapies s.r.l.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-25
- Primary completion
- 2026-07-29
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.